BIOMAT Database Logo BIOMAT Database Logo

Identification of novel benzimidazole derivatives as anti-Trypanosoma cruzi agents: solid-phase synthesis, structure-activity relationships and molecular docking studies. 2013

Natalia Ríos, and Javier Varela, and Estefania Birriel, and Mercedes González, and Hugo Cerecetto, and Alicia Merlino, and Williams Porcal
Grupo de Química Medicinal, Laboratorio de Química Orgánica, Facultad de Ciencias-Facultad de Química, Universidad de la República, Iguá 4225, Montevideo 11400, Uruguay.

BACKGROUND In this paper, we report the solid-phase synthesis of 33 novel 1,2,5-tri-substituted benzimidazole derivatives and their in vitro activity on cruzipain and Trypanosoma cruzi epimastigotes. RESULTS Seven compounds were potent inhibitors of T. cruzi growth with IC50 values in the range 6-16 µM. Applying structure-activity relationships and principal component analysis strategies we were able to determine ring substituent effects and physicochemical properties that are important for the antichagasic activity of these novel derivatives, as well as get an insight into their possible mechanisms of action. Molecular docking studies revealed the binding orientation of the ligands in the active site of cruzipain providing new guidelines for the further design of better inhibitors. CONCLUSIONS Compound 2a constitute a promising hit compound for novel anti-T. cruzi agents showing that the benzimidazole scaffold may represent an interesting therapeutic alternative for the treatment of Chagas disease.

UI MeSH Term Description Entries
D002460 Cell Line Established cell cultures that have the potential to propagate indefinitely. Cell Lines,Line, Cell,Lines, Cell
D002470 Cell Survival The span of viability of a cell characterized by the capacity to perform certain functions such as metabolism, growth, reproduction, some form of responsiveness, and adaptability. Cell Viability,Cell Viabilities,Survival, Cell,Viabilities, Cell,Viability, Cell
D003546 Cysteine Endopeptidases ENDOPEPTIDASES which have a cysteine involved in the catalytic process. This group of enzymes is inactivated by CYSTEINE PROTEINASE INHIBITORS such as CYSTATINS and SULFHYDRYL REAGENTS.
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D001562 Benzimidazoles Compounds with a BENZENE fused to IMIDAZOLES.
D001665 Binding Sites The parts of a macromolecule that directly participate in its specific combination with another molecule. Combining Site,Binding Site,Combining Sites,Site, Binding,Site, Combining,Sites, Binding,Sites, Combining
D013329 Structure-Activity Relationship The relationship between the chemical structure of a compound and its biological or pharmacological activity. Compounds are often classed together because they have structural characteristics in common including shape, size, stereochemical arrangement, and distribution of functional groups. Relationship, Structure-Activity,Relationships, Structure-Activity,Structure Activity Relationship,Structure-Activity Relationships
D014344 Trypanocidal Agents Agents destructive to the protozoal organisms belonging to the suborder TRYPANOSOMATINA. Trypanocidal Drugs,Trypanocides,Trypanosomicidal Agents,Trypanosomicides,Agents, Trypanocidal,Agents, Trypanosomicidal,Drugs, Trypanocidal
D014349 Trypanosoma cruzi The agent of South American trypanosomiasis or CHAGAS DISEASE. Its vertebrate hosts are man and various domestic and wild animals. Insects of several species are vectors. Trypanosoma cruzus,cruzi, Trypanosoma
D015195 Drug Design The molecular designing of drugs for specific purposes (such as DNA-binding, enzyme inhibition, anti-cancer efficacy, etc.) based on knowledge of molecular properties such as activity of functional groups, molecular geometry, and electronic structure, and also on information cataloged on analogous molecules. Drug design is generally computer-assisted molecular modeling and does not include PHARMACOKINETICS, dosage analysis, or drug administration analysis. Computer-Aided Drug Design,Computerized Drug Design,Drug Modeling,Pharmaceutical Design,Computer Aided Drug Design,Computer-Aided Drug Designs,Computerized Drug Designs,Design, Pharmaceutical,Drug Design, Computer-Aided,Drug Design, Computerized,Drug Designs,Drug Modelings,Pharmaceutical Designs

Related Publications

Natalia Ríos, and Javier Varela, and Estefania Birriel, and Mercedes González, and Hugo Cerecetto, and Alicia Merlino, and Williams Porcal
New imidazolidine derivatives as anti-Trypanosoma cruzi agents: structure-activity relationships.
December 2012, Parasitology research,
Natalia Ríos, and Javier Varela, and Estefania Birriel, and Mercedes González, and Hugo Cerecetto, and Alicia Merlino, and Williams Porcal
New potent imidazoisoquinolinone derivatives as anti-Trypanosoma cruzi agents: biological evaluation and structure-activity relationships.
February 2009, Bioorganic & medicinal chemistry,
Natalia Ríos, and Javier Varela, and Estefania Birriel, and Mercedes González, and Hugo Cerecetto, and Alicia Merlino, and Williams Porcal
Design, synthesis and molecular docking studies of novel N-arylsulfonyl-benzimidazoles with anti Trypanosoma cruzi activity.
March 2019, European journal of medicinal chemistry,
Natalia Ríos, and Javier Varela, and Estefania Birriel, and Mercedes González, and Hugo Cerecetto, and Alicia Merlino, and Williams Porcal
Synthesis, antioxidant activity, molecular docking and ADME studies of novel pyrrole-benzimidazole derivatives.
January 2022, Turkish journal of chemistry,
Natalia Ríos, and Javier Varela, and Estefania Birriel, and Mercedes González, and Hugo Cerecetto, and Alicia Merlino, and Williams Porcal
Imidazolidines as new anti-Trypanosoma cruzi agents: biological evaluation and structure-activity relationships.
March 2008, Bioorganic & medicinal chemistry,
Natalia Ríos, and Javier Varela, and Estefania Birriel, and Mercedes González, and Hugo Cerecetto, and Alicia Merlino, and Williams Porcal
Synthesis, Biological Evaluation and Molecular Docking of New Benzenesulfonylhydrazone as Potential anti-Trypanosoma cruzi Agents.
January 2017, Medicinal chemistry (Shariqah (United Arab Emirates)),
Natalia Ríos, and Javier Varela, and Estefania Birriel, and Mercedes González, and Hugo Cerecetto, and Alicia Merlino, and Williams Porcal
Synthesis, biological evaluation and molecular docking studies of novel benzimidazole derivatives.
February 2018, Computational biology and chemistry,
Natalia Ríos, and Javier Varela, and Estefania Birriel, and Mercedes González, and Hugo Cerecetto, and Alicia Merlino, and Williams Porcal
Synthesis, biological evaluation and molecular docking studies of novel diosgenin derivatives as anti-inflammatory agents.
October 2022, Bioorganic chemistry,
Natalia Ríos, and Javier Varela, and Estefania Birriel, and Mercedes González, and Hugo Cerecetto, and Alicia Merlino, and Williams Porcal
Novel Substituted Pyrimidine Derivatives as Potential Anti-Alzheimer's Agents: Synthesis, Biological, and Molecular Docking Studies.
February 2024, ACS chemical neuroscience,
Natalia Ríos, and Javier Varela, and Estefania Birriel, and Mercedes González, and Hugo Cerecetto, and Alicia Merlino, and Williams Porcal
Design, synthesis, molecular docking, and dynamic studies of novel thiazole derivatives incorporating benzimidazole moiety and assessment as antibacterial agents.
July 2023, Molecular diversity,
Copied contents to your clipboard!